Jane Street’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Jane Street’s Portfolio FMED Stock Details FMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Sell	49,860 -3,246	-6%	-$82.2K	﹤0.01%	5792
2026 Q1	$1.3M	Sell	53,106 -38,308	-42%	-$996K	﹤0.01%	5926
2025 Q4	$2.47M	Buy	91,414 +44,630	+95%	+$1.2M	﹤0.01%	4420
2025 Q3	$1.17M	Buy	46,784 +26,157	+127%	+$632K	﹤0.01%	5970
2025 Q2	$494K	Sell	20,627 -45,755	-69%	-$1.07M	﹤0.01%	6947
2025 Q1	$1.57M	Buy	66,382 +499	+0.8%	+$12.6K	﹤0.01%	4771
2024 Q4	$1.62M	Buy	65,883 +4,541	+7%	+$117K	﹤0.01%	4484
2024 Q3	$1.61M	Buy	61,342 +40,924	+200%	+$1.03M	﹤0.01%	4924
2024 Q2	$491K	Sell	20,418 -17,936	-47%	-$433K	﹤0.01%	7048
2024 Q1	$979K	Sell	38,354 -73,891	-66%	-$1.83M	﹤0.01%	5454
2023 Q4	$2.72M	Buy	112,245 +79,246	+240%	+$1.72M	﹤0.01%	3797
2023 Q3	$730K	Sell	32,999 -3,439	-9%	-$82.3K	﹤0.01%	5649
2023 Q2	$915K	Buy	+36,438	New	+$916K	﹤0.01%	5340

Other funds holding FMED

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return

GEA

Glen Eagle Advisors Kingston, New Jersey $793M AUM 21.06% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

Jane Street's FMED Position: Q2 2026 in Review

Jane Street reduced its Fidelity Disruptive Medicine ETF (FMED) stake by 6.1% in Q2 2026, selling an estimated $82.2K and leaving 49,860 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #5792.

Jane Street first reported a position in FMED in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.72M in Q4 2023. 11 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

Jane Street held 49,860 shares of Fidelity Disruptive Medicine ETF worth $1.42M as of Q2 2026.
Jane Street sold 3,246 Fidelity Disruptive Medicine ETF shares in Q2 2026, an estimated $82.2K.
Fidelity Disruptive Medicine ETF made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5792 holding.
Jane Street first reported a position in Fidelity Disruptive Medicine ETF in Q2 2023 and has held it in 13 quarters since.
Jane Street's Fidelity Disruptive Medicine ETF position peaked at $2.72M in Q4 2023.
11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.